320 related articles for article (PubMed ID: 25586224)
1. Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi.
Kaulich M; Lee YJ; Lönn P; Springer AD; Meade BR; Dowdy SF
Nucleic Acids Res; 2015 Apr; 43(7):e45. PubMed ID: 25586224
[TBL] [Abstract][Full Text] [Related]
2. Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing.
Kaulich M; Dowdy SF
Nucleic Acid Ther; 2015 Dec; 25(6):287-96. PubMed ID: 26540648
[TBL] [Abstract][Full Text] [Related]
3. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9.
Matsunaga T; Yamashita JK
Biochem Biophys Res Commun; 2014 Feb; 444(2):158-63. PubMed ID: 24462858
[TBL] [Abstract][Full Text] [Related]
4. Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
Bartkowiak B; Yan C; Greenleaf AL
Biochim Biophys Acta; 2015 Sep; 1849(9):1179-87. PubMed ID: 26189575
[TBL] [Abstract][Full Text] [Related]
5. Correction of a genetic disease in mouse via use of CRISPR-Cas9.
Wu Y; Liang D; Wang Y; Bai M; Tang W; Bao S; Yan Z; Li D; Li J
Cell Stem Cell; 2013 Dec; 13(6):659-62. PubMed ID: 24315440
[TBL] [Abstract][Full Text] [Related]
6. Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells.
Gellhaus K; Cornu TI; Heilbronn R; Cathomen T
Hum Gene Ther; 2010 May; 21(5):543-53. PubMed ID: 20021219
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 allows efficient and complete knock-in of a destabilization domain-tagged essential protein in a human cell line, allowing rapid knockdown of protein function.
Park A; Won ST; Pentecost M; Bartkowski W; Lee B
PLoS One; 2014; 9(4):e95101. PubMed ID: 24743236
[TBL] [Abstract][Full Text] [Related]
8. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
Peng J; Zhou Y; Zhu S; Wei W
FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
[TBL] [Abstract][Full Text] [Related]
10. Genetic knockouts and knockins in human somatic cells.
Rago C; Vogelstein B; Bunz F
Nat Protoc; 2007; 2(11):2734-46. PubMed ID: 18007609
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 mediated generation of stable chondrocyte cell lines with targeted gene knockouts; analysis of an aggrecan knockout cell line.
Yang M; Zhang L; Stevens J; Gibson G
Bone; 2014 Dec; 69():118-25. PubMed ID: 25260929
[TBL] [Abstract][Full Text] [Related]
12. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
Hu B; Mitra J; van den Heuvel S; Enders GH
Mol Cell Biol; 2001 Apr; 21(8):2755-66. PubMed ID: 11283255
[TBL] [Abstract][Full Text] [Related]
13. A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
Zhu Z; Verma N; González F; Shi ZD; Huangfu D
Stem Cell Reports; 2015 Jun; 4(6):1103-11. PubMed ID: 26028531
[TBL] [Abstract][Full Text] [Related]
14. Efficient CRISPR-mediated gene targeting and transgene replacement in the beetle Tribolium castaneum.
Gilles AF; Schinko JB; Averof M
Development; 2015 Aug; 142(16):2832-9. PubMed ID: 26160901
[TBL] [Abstract][Full Text] [Related]
15. Precise and efficient genome editing in zebrafish using the CRISPR/Cas9 system.
Irion U; Krauss J; Nüsslein-Volhard C
Development; 2014 Dec; 141(24):4827-30. PubMed ID: 25411213
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
Auer TO; Del Bene F
Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-based generation of knockdown mice by intronic insertion of artificial microRNA using longer single-stranded DNA.
Miura H; Gurumurthy CB; Sato T; Sato M; Ohtsuka M
Sci Rep; 2015 Aug; 5():12799. PubMed ID: 26242611
[TBL] [Abstract][Full Text] [Related]
18. Generation of eGFP and Cre knockin rats by CRISPR/Cas9.
Ma Y; Ma J; Zhang X; Chen W; Yu L; Lu Y; Bai L; Shen B; Huang X; Zhang L
FEBS J; 2014 Sep; 281(17):3779-90. PubMed ID: 25039742
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-mediated targeted mutagenesis in the liverwort Marchantia polymorpha L.
Sugano SS; Shirakawa M; Takagi J; Matsuda Y; Shimada T; Hara-Nishimura I; Kohchi T
Plant Cell Physiol; 2014 Mar; 55(3):475-81. PubMed ID: 24443494
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9: a new and promising player in gene therapy.
Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
